Titan Pharmaceuticals (TTNP) News Today $4.03 +0.03 (+0.75%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Contrasting Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP)November 5 at 2:13 AM | americanbankingnews.comStockNews.com Initiates Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)November 4 at 4:03 AM | americanbankingnews.comTitan Pharmaceuticals (NASDAQ:TTNP) Receives New Coverage from Analysts at StockNews.comOctober 26, 2024 | americanbankingnews.comSanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly BeatOctober 25, 2024 | msn.comTitan Pharmaceuticals, Inc. (TTNP)October 17, 2024 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of ShareholdersSeptember 9, 2024 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, CFB, TTNP, DFS on Behalf of ShareholdersSeptember 5, 2024 | stockhouse.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. – TTNPSeptember 5, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNPSeptember 4, 2024 | prnewswire.comTitan Pharmaceuticals Share Price (TTNP.US)August 24, 2024 | lse.co.ukShareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public ShareholdersAugust 23, 2024 | prnewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Titan Pharmaceuticals, Inc. MergerAugust 22, 2024 | markets.businessinsider.comCrude Oil Falls; Palo Alto Networks Shares Jump After Q4 EarningsAugust 21, 2024 | msn.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of ShareholdersAugust 20, 2024 | stockhouse.comTitan Pharmaceuticals Shares Double on Reverse Merger DealAugust 20, 2024 | marketwatch.comTTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to ShareholdersAugust 19, 2024 | businesswire.comTitan Pharmaceuticals in Reverse Merger Agreement With KE Sdn. Bhd.August 19, 2024 | marketwatch.comTitan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.August 19, 2024 | globenewswire.comTTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024August 15, 2024 | investorplace.comTTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023May 16, 2024 | investorplace.comTTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024May 16, 2024 | investorplace.comIndia's Titan misses Q4 profit view as surging gold prices dampen demandMay 3, 2024 | reuters.comTitan Pharmaceuticals Inc (TTNP)March 2, 2024 | uk.investing.comTitan Pharmaceuticals, Inc. (TN70.F)February 20, 2024 | au.finance.yahoo.comTrading was temporarily halted for "TTNP" at 09:02 AM with a stated reason of "LULD pause."February 8, 2024 | marketbeat.comTitan Pharmaceuticals Inc TTNPFebruary 3, 2024 | morningstar.comTitan Pharmaceuticals, Inc.: Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaJanuary 26, 2024 | finanznachrichten.deTitan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaJanuary 25, 2024 | finance.yahoo.comTitan Pharma Stock (NASDAQ:TTNP) Dividends: History, Yield and DatesJanuary 10, 2024 | benzinga.comTrading was temporarily halted for "TTNP" at 07:01 PM with a stated reason of "News pending."January 9, 2024 | marketbeat.comTitan Pharmaceuticals, Inc.: Titan Pharmaceuticals Announces Reverse Stock Split and RatioDecember 29, 2023 | finanznachrichten.deBarbie, the Titan submersible and everything else we Googled in 2023December 28, 2023 | washingtonpost.comTitan Pharmaceuticals Announces Reverse Stock Split and RatioDecember 28, 2023 | finance.yahoo.comTitan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsOctober 16, 2023 | finance.yahoo.comTitan Pharmaceuticals reports $9.5M private placement of convertible preferred stockSeptember 18, 2023 | seekingalpha.comTitan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockSeptember 18, 2023 | finance.yahoo.comUnveiling Titan Pharmaceuticals (TTNP)'s Value: Is It Really Priced Right? A Comprehensive GuideAugust 28, 2023 | finance.yahoo.comTitan Pharmaceuticals (TTNP) Stock Soars on FDA Committee Treatment ApprovalAugust 13, 2023 | thestreet.comTitan Pharmaceuticals Announces Sale of Certain ProNeura AssetsJuly 27, 2023 | finance.yahoo.comPatents, lawsuits, safety concerns — then tragedy. A timeline of OceanGate's Titan sub.June 29, 2023 | usatoday.comTTNP - Titan Pharmaceuticals, Inc.May 26, 2023 | finance.yahoo.comWatch: Prowling tiger bows to ‘titan herd’ of elephantsMay 23, 2023 | sports.yahoo.comTTNP Titan Pharmaceuticals, Inc.March 22, 2023 | seekingalpha.comTitan Pharmaceuticals Provides Shareholder UpdateDecember 15, 2022 | finance.yahoo.comTitan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.December 12, 2022 | nz.finance.yahoo.comChapel Hill surgical tech company shapes plan to keep Nasdaq listingNovember 21, 2022 | bizjournals.comTitan Pharmaceuticals Third Quarter 2022 Earnings: US$0.18 loss per share (vs US$0.19 loss in 3Q 2021)November 17, 2022 | finance.yahoo.comTitan, GAIL, TVS Motor, Britannia & Other Stocks to Release Q2 Results TodayNovember 4, 2022 | msn.comTitan Pharmaceuticals Announces Board Expansion...August 17, 2022 | benzinga.comTitan Pharmaceuticals Announces Board Expansion and Management ChangesAugust 16, 2022 | finance.yahoo.com Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW TTNP Media Mentions By Week TTNP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TTNP News Sentiment▼0.000.46▲Average Medical News Sentiment TTNP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TTNP Articles This Week▼10▲TTNP Articles Average Week Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioCardia News Longeveron News NRx Pharmaceuticals News Avalo Therapeutics News Biora Therapeutics News Alzamend Neuro News Calidi Biotherapeutics News CERo Therapeutics News IN8bio News Aytu BioPharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TTNP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TTNP Stock Alerts